Generic HIV prevention drug coming in 2020, Gilead says

By Tim Fitzsimons

Gilead Sciences announced Wednesday that a generic version of Truvada will be available in September 2020, one year earlier than expected.

Truvada is the pill used for HIV pre-exposure prophylaxis, or PrEP. When taken daily, Truvada prevents HIV transmission.

“Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required,” wrote Douglas Brooks, Gilead’s executive director for community engagement, in an email shared with NBC News by the advocacy group PrEP4All.

The information about generic Truvada is also disclosed on page 35 of a Gilead SEC filing released Wednesday morning.

http://platform.twitter.com/widgets.js